Scientists face present day hurdles, including pandemic- and war-driven supply disruptions, which jeopardize the diagnostic industry’s ability to deliver lifesaving assays. In diagnostic assay development, researchers can now turn to the availability, performance, and reliability of recombinants.

Download this ebook from Scripps Laboratories to learn how recombinant proteins move the diagnostic industry forward, in endocrinology, metabolism, cardiology, and beyond.

Sponsored by